FUS/TLS is a novel mediator of androgen-dependent cell-cycle progression and prostate cancer growth. (2011)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.CAN-10-0874

PubMed Identifier: 21169411

Publication URI: http://europepmc.org/abstract/MED/21169411

Type: Journal Article/Review

Volume: 71

Parent Publication: Cancer research

Issue: 3

ISSN: 0008-5472